25 shown
| # | Company | Score | Growth | Margin | Mkt cap | F |
|---|---|---|---|---|---|---|
| 1 | NVMINOVA LTD. | 100 | 31% | 29% | $15.0B | 3 |
| 2 | KLACKLA CORP | 97 | 24% | 36% | $307.7B | 9 |
| 3 | ISRGINTUITIVE SURGICAL INC | 93 | 21% | 28% | $150.9B | 6 |
| 4 | PODDINSULET CORP | 90 | 31% | 10% | $11.4B | 6 |
| 5 | BSXBOSTON SCIENTIFIC CORP | 87 | 20% | 17% | $67.1B | 8 |
| 6 | GMEDGLOBUS MEDICAL INC | 83 | 17% | 18% | $10.9B | 9 |
| 7 | COHRCOHERENT CORP. | 80 | 23% | 7% | $65.2B | 7 |
| 8 | RMDRESMED INC | 77 | 10% | 27% | $30.4B | 8 |
| 9 | DXCMDEXCOM INC | 73 | 16% | 18% | $27.5B | 8 |
| 10 | PENPenumbra Inc | 70 | 17% | 12% | $12.5B | 7 |
| 11 | EWEdwards Lifesciences Corp | 67 | 12% | 17% | $54.3B | 5 |
| 12 | SYKSTRYKER CORP | 63 | 11% | 13% | $125.2B | 4 |
| 13 | STESTERIS plc | 60 | 9% | 13% | $21.3B | 9 |
| 14 | WSTWEST PHARMACEUTICAL SERVICES INC | 57 | 6% | 17% | $25.8B | 7 |
| 15 | MDTMedtronic plc | 53 | 8% | 13% | $106.5B | 8 |
| 16 | TMOTHERMO FISHER SCIENTIFIC INC. | 50 | 4% | 15% | $194.5B | — |
| 17 | MDLNMedline Inc. | 47 | 11% | 4% | $36.5B | — |
| 18 | SOLVSolventum Corp | 43 | 1% | 19% | $13.6B | 6 |
| 19 | ZBHZIMMER BIOMET HOLDINGS, INC. | 40 | 7% | 9% | $16.9B | 5 |
| 20 | SNNSMITH & NEPHEW PLC | 37 | 6% | 10% | $12.8B | — |
| 21 | BDXBECTON DICKINSON & CO | 33 | 8% | 5% | $43.6B | 8 |
| 22 | GEHCGE HealthCare Technologies Inc. | 30 | 5% | 10% | $29.8B | 5 |
| 23 | MMM3M CO | 27 | 2% | 11% | $83.7B | 6 |
| 24 | COOCOOPER COMPANIES, INC. | 23 | 5% | 6% | $14.5B | 5 |
| 25 | ONTOONTO INNOVATION INC. | 20 | 2% | 10% | $15.3B | 4 |
Ranked by percentile of (0.6 × revenue growth + 0.4 × net margin) within the Medical Devices · large-cap cohort (31 companies). Score 0–100. Click a column to re-sort; Best/Worst flip the cohort ranking.